Pharmacy Times
DECEMBER 14, 2024
Emerging research in triple-negative breast cancer highlights the promise of molecular-based approaches to improve treatment outcomes.
STAT
DECEMBER 14, 2024
Novo Holdings, the parent company of Novo Nordisk, can proceed with its planned $16.5 billion acquisition of Catalent, a leading contract drug manufacturer, after U.S. regulators declined to challenge the deal following months of scrutiny. The companies expect to close the transaction in the next several days, after a deadline passed for the U.S. Federal Trade Commission to raise objections and other regulatory conditions were fulfilled, according to statements issued by Novo Nordisk and Catalen
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
DECEMBER 14, 2024
Advancements in prevention address cancer risk in high-risk patients and BRCA mutation carriers.
STAT
DECEMBER 14, 2024
A U.S. government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a drug discount program, the third time in recent months that a major pharmaceutical company has been threatened with such a step. In a Dec. 13 letter , the Health Resources & Services Administration said that if Sanofi proceeds with its plan, the company could be terminated from the 340B Drug Discount Program.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
DECEMBER 14, 2024
AI-powered analysis of mammography images can identify women at high long-term risk of breast cancer, enabling targeted prevention strategies.
STAT
DECEMBER 14, 2024
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
STAT
DECEMBER 14, 2024
The phone call to Steward Health Care chief executive Ralph de la Torre from the state’s top health official came days after a veteran nurse at Steward’s Good Samaritan Medical Center was fired for a devastating lapse — one that a federal investigation later deemed a violation of basic care. On Sept. 13, 2023, a triage nurse in the Brockton hospital’s overwhelmed emergency department received a plea for help from a patient in the registration line.
Expert insights. Personalized for you.
123 
Let's personalize your content